References
- Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto H, Daikuhara Y. Partial purification and characterization of hepatocyte growth factor from plasma of patients with fulminant hepatic failure. J Clin Invest 1988; 81: 414–9.
- Miki C, Iriyama K, Strain A, Harrison JD, Hirono S, Gunson BK, Sherwell JM, Sunsuki H, McMaster P. Clinical significance of serum hepatocyte growth factor in orthotopic liver transplantation. Surgery 1996; 119: 505–10.
- Nagaike M, Hirao S, Tajima H, Noji S, Taniguchi S, Matsumoto K, Nakamura T. Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J Biol Chem 1991; 266: 22781–84.
- Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901–8.
- Jiang WG, Hiscox S, Matsumoto K, Nakamura T. Hepatocyte growth factor/scatter factor, its mole-cular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 1999; 29: 209–48.
- Nusrat A, Parkos CA, Bacarra AE, Godowski PJ, Delp-Archer C, Rosen EM, Madara JL. Hepato-cyte growth factor effects on epithelia. Regulation of intracellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium. J Clin Invest 1994; 93: 2056— 65.
- Nayeri F, Nilsson I, Brudin L, Fryden A, S6derstr6m C. High hepatocyte growth factor levels in the acute stage of community-acquired infectious diseases. Scand J Infect Dis 2002; 34: 127 — 30.
- Sakon M, Kita Y, Umeshita K, Gotoh M, Kanai T, Kawasaki T, Kambayashi J, Monden M. Plasma hepatocyte growth factor levels are increased in systemic inflammatory response syndrome. Surg Today (Jpn J Surg) 1996; 26: 236–41.
- Ueda T, Takeyama Y, Hon Y, Nishikawa J, Yamamoto M, Saitoh Y. Hepatocyte growth factor in assessment of acute pancreatitis: compar-ison with C-reactive protein and interleukin-6, J Gastroenterol 1997; 32: 63–70.
- Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 1995; 21: 106–12.
- Taman M, Liu Y, Tolbert E, Dworkin LD. Increased urinary hepatocyte growth factor excre-tion in human acute renal failure. Clin Nephrol 1997; 48: 241–5.
- Tajima H, Higuchi O, Mizuno K, Nakamura T. Tissue distribution of hepatocyte growth factor and its exclusive down-regulation in regenerating organ after injury. J Biol Chem 1992; 111: 401 —6.
- Nayeri F, Nilsson I, Hagberg L, Brudin L, Roberg M, S6derstr6m C, Forsberg P. Hepatocyte growth factor (HGF) levels in cerebrospinal fluid: a comparison between acute bacterial/non-bacterial meningitis. J Infect Dis 2000; 181: 2092–4.
- Nayeri F, Almer S, Brudin L, Nilsson I, Akerlind B, Forsberg P. High hepatocyte growth factor levels in faeces during acute infectious gatroenter-itis. Scand J Infect Dis 2003; 35: 858–62.
- Nayeri F, Brudin L, Nilsson I, Forsberg P. Sample handling and stability of hepatocyte growth factor in serum during infection. Cytokine 2002; 19: 201–5.
- Dahlberg G. Statistical methods for medical and biological students. 2nd ed. London: Goerge Allen & Unwin Ltd.; 1940.
- Nicholls S, Stephens S, Braegger CP, walker-Smith JA, Mac Donald TT. Cytokines in stools of children with inflammatory bowel disease or infective diarrhea. J Clin Pathol 1993; 46: 757–60.
- Harendra de Silva DG, Mendis LN, Sheron N, Alexander GJ, Candy DC, Chart H, et al. Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection. Gut 1993; 34: 194–8.
- Depuydt CE, Bosmans E, Zalata A, Schoonjans F, Comhaire FH. The relation between reactive oxygen species and cytokines in andrological patients with or without male accessory gland infection. J Androl 1996; 17: 699–707.
- Ferguson A, Humphreys KA, Croft NM. Techni-cal report: results of immunological tests on faecal extracts are likely to be extremely misleading. Clin Exp Immunol 1995; 99: 70–5.
- Choudari CP, O'Mahony S, Brydon G, Mwantembe O, Ferguson A. Gut lavage fluid protein concentrations: objective measures of disease activity in inflammatory bowel disease. Gastroenterology 1993; 104: 1064–71.
- Nayeri F, Millinger E, Nilsson I, Zetterstr6m O, Brudin L, Forsberg P. Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia. Respir Med 2002; 96: 115–9.